Vitality Biopharma Retains DelMorgan & Co. to Explore Strategic Alternatives
CLEVELAND, OHIO – (September 25, 2020) – Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”), a drug development company dedicated to unlocking the unique therapeutic powers of cannabinoids, today announced that it has retained DelMorgan & Co., an internationally recognized investment banking firm, to advise Vitality on its strategic alternatives, including potential financings, asset...